Patent · US Active

Cervical cancer diagnosing method and diagnostic kit for same

US10072302B2 · kind B2 · utility

0Cited by
1References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 5, 2013
Grant dateSep 11, 2018
Priority date
Expiry dateApr 10, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

There are provided an improved cervical cancer diagnosing method and a diagnostic kit for same. According to the present invention, it is possible to more rapidly and accurately provide a patient group requiring a clinical treatment and a prevention treatment in terms of a technical aspect to predict that the limitation of the existing HPV DNA test method can be overcome, automate the RNA extraction from eliminated cells, and more rapidly provide more objective and accurate results because the result analysis can be performed by software by using the real-time RT-PCR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.